FIELD: medicine, psychiatry, neurology.
SUBSTANCE: therapeutic scheme in patients that use nootropic preparations should be supplemented with immunomodulator Halavit by a course. It is necessary to carry out 15 intramuscular injections per 100 mg. Such therapy enables to raise the impact of Halavit to higher power at treating asthenic disorders with nootropic preparations and obtain immunomodulating and smooth anxiolytic effect. That leads to improved tolerance of antiasthenic therapy and more qualitative and quicker social adaptation in such patients.
EFFECT: higher efficiency of therapy.
3 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING POST-ABSTINENT STATES IN CASE OF ALCOHOLISM | 2005 |
|
RU2304970C2 |
USE OF AMIDE N-(6-PHENYLHEXANOYL) GLYCYL-L-TRYPTOPHANE (GB-115) AS AN AGENT HAVING ANXIOLYTIC PROPERTIES WITH AN ACTIVATING COMPONENT | 2018 |
|
RU2709013C1 |
METHOD FOR TREATING PATIENTS AT KAPOSI'S ECZEMA HERPETICUM AT DEVELOPING CONVERSION DISORDER | 2006 |
|
RU2320345C1 |
EARLY DIAGNOSTIC TECHNIQUE FOR CLINICAL COURSE AND OUTCOME OF NEUROTIC, STRESS-RELATED CONNECTED WITH STRESS, SOMATOFORM AND NEUROSIS-LIKE DISORDERS | 2009 |
|
RU2427841C2 |
USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
METHOD OF PREDICTING EFFICIENCY OF TREATMENT WITH ADAPTOL IN WOMEN IN POSTMENOPAUSAL PERIOD WITH ARTERIAL HYPERTENSION | 2010 |
|
RU2459580C2 |
METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
DIAGNOSTIC TECHNIQUE FOR ASTHENIC SYNDROME IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2709105C1 |
METHOD OF TREATMENT OF PATIENTS WITH PSYCHOGENIC AND SOMATOGENIC BOUNDARY PSYCHIC DISORDERS | 1995 |
|
RU2121348C1 |
Authors
Dates
2008-03-20—Published
2005-11-25—Filed